Epistasis between DSG1 and HLA class II genes in pemphigus foliaceus

Genes and Immunity

Volumn 3, Issue 4, 2002, Pages 205-210

  Martel, Philippe ^a   Gilbert, D ^a   Busson, M ^b   Loiseau, P ^b   Lepage, V ^b   Drouot, L ^a   Delaporte, E ^c   Prost, C ^b   Joly, P ^a   Charron, D ^b   Tron, F ^a  

^a HÔPITAL CHARLES NICOLLE   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Autoimmunity; Desmoglein; Epistasis; Genetics; HLA; Pemphigus

Indexed keywords

AUTOANTIBODY; DESMOGLEIN 1; HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; AUTOANTIGEN; CADHERIN;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CAUCASIAN; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FRANCE; GENE INTERACTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC CODE; GENETIC EPISTASIS; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MALE; PEMPHIGUS FOLIACEUS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; GENE; GENETICS; IMMUNOLOGY; PEMPHIGUS;

PEMPHIGUS;

AUTOANTIGENS; CADHERINS; DESMOGLEIN 1; EPISTASIS, GENETIC; EUROPEAN CONTINENTAL ANCESTRY GROUP; FRANCE; GENES, MHC CLASS II; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PEMPHIGUS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 0036615242     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6363839     Document Type: Article

References (31)

1. Marrack P, Kappler J, Kotzin BL. Autoimmune disease: why and where it occurs. Nat Med 2001; 7: 899-905.
2. Todd JA. From genome to aetiology in a multifactorial disease, type 1 diabetes. Bioessays 1999; 21: 164-174.
3. Garchon HJ, Djabiri F, Viard JP, Gajdos P, Bach JF. Involvement of human muscle acetylcholine receptor alpha-subunit gene (CHRNA) in susceptibility to myasthenia gravis. Proc Natl Acad Sci USA 1994; 91: 4668-4672.
4. Djabiri F, Caillat-Zucman S, Gajdos P et al. Association of the AChRalpha-subunit gene (CHRNA), DQA10101, and the DR3 haplotype in myasthenia gravis. Evidence for a three-gene disease model in a subgroup of patients. J Autoimmun 1997; 10: 407-413.
5. Martel P, Joly P. Pemphigus: autoimmune diseases of desmosome. Clinics in Dermatol 2001; 19: 662-674.
6. Wheeler GN, Parker AE, Thomas CL et al. Desmosomal glycoprotein DGI, a component of intercellular desmosome junctions, is related to the cadherin family of cell adhesion molecules. Proc Natl Acad Sci USA 1991; 88: 4796-4800.
7. Amagai M, Hashimoto T, Green KJ, Shimizu N, Nishikawa T. Antigen-specific immunoadsorption of pathogenic autoantibodies in pemphigus foliaceus. J Invest Dermatol 1995; 104: 895-901.
8. Amagai M, Tsunoda K, Zillikens D, Nagai T, Nishikawa T. The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile. J Am Acad Dermatol 1999; 40: 167-170.
9. Ishii K, Amagai M, Hall RP et al. Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins. J Immunol 1997; 159: 2010-2017.
10. Mahoney MG, Wang ZH, Stanley JR. Pemphigus vulgaris and pemphigus foliaceus antibodies are pathogenic in plasminogen activator knockout mice. J Invest Dermatol 1999; 113: 22-25.
11. Mahoney MG, Wang Z, Rothenberger K, Koch PJ, Amagai M, Stanley JR. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. J Clin Invest 1999; 103: 461-468.
12. Lin MS, Fu CL, Aoki V et al. Desmoglein-1-specific T lymphocytes from patients with endemic pemphigus foliaceus (fogo selvagem). J Clin Invest 2000; 105: 207-213.
13. Moraes JR, Moraes ME et al. HLA antigens and risk for development of pemphigus foliaceus (fogo selvagem) in endemic areas of Brazil. Immunogenetics 1991; 33: 388-391.
14. Moraes ME, Fernandez-Vina M, Lazaro A et al. An epitope in the third hypervariable region of the DRB1 gene is involved in the susceptibility to endemic pemphigus foliaceus (fogo selvagem) in three different Brazilian populations. Tissue Antigens 1997; 49: 3540.
15. Loiseau P, Lecleach L, Prost C et al. HLA class II polymorphism contributes to specify desmoglein derived pepticles in pemphigus vulgaris and pemphigus foliaceus. J Autoimmun 2000; 15: 67-73.
16. Lombardi ML, Mercuro O, Ruocco V et al. Common human leukocyte antigen alleles in pemphigus vulgaris and pemphigus foliaceus Italian patients. J Invest Dermatol 1999; 113: 107-110.
17. Miyagawa S, Amagai M, Niizeki H et al. HLA-DRB1 polymorphism and autoimmune responses to desmogleins in Japanese patients with pemphigus. Tissue Antigens 1999; 54: 333-340.
18. Martel P, Gilbert D, Drouot L et al. A polymorphic variant of the gene coding desmoglein 1, the target autoantigen of pemphigus foliaceus, is associated with the disease. Genes Immun 2001; 2: 41-43.
19. Wakeland EK, Wandstrat AE, Liu K, Morel L. Genetic dissection of systemic lupus erythematosus. Curr Opin Immunol 1999; 11: 701-707.
20. Gaffney PM, Kearns GM, Shark KB et al. A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families. Proc Natl Acad Sci USA 1998; 95: 14875-14879.
21. Morel L, Tian XH, Croker BP, Wakeland EK. Epistatic modifiers of autoimmunity in a murine model of lupus nephritis. Immunity 1999; 11: 131-139.
22. Bennett ST, Lucassen AM, Gough SC et al. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nat Genet 1995; 9: 284292.
23. Lin MS, Swartz SJ, Lopez A, Ding X, Fairley JA, Diaz LA. T lymphocytes from a subset of patients with pemphigus vulgaris respond to both desmoglein-3 and desmoglein-1. J Invest Dermatol 1997; 109: 734-737.
24. Cordell HJ, Todd JA, Bennett ST, Kawaguchi Y, Farrall M. Two-locus maximum lod score analysis of a multifactorial trait: joint consideration of IDDM2 and IDDM4 with IDDM1 in type 1 diabetes. Am J Hum Genet 1995; 57: 920-934.
25. Wucherpfennig KW, Yu B, Bhol K et al. Structural basis for major histocompatibility complex (MHC)-linked susceptibility to autoimmunity: charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris. Proc Natl Acad Sci USA 1995; 92: 11935-11939.
26. Joly P, Thomine E, Gilbert D et al. Overlapping distribution of autoantibody specificities in paraneoplastic pemphigus and pemphigus vulgaris. J Invest Dermatol 1994; 103: 65-72.
27. Jiao D, Bystryn JC. Sensitivity of indirect immunofluorescence, substrate specificity, and immunoblotting in the diagnosis of pemphigus. J Am Acad Dermatol 1997; 37: 211-216.
28. Mercier B, al Daccak R, Samaan A et al. HLA-DRB and -DBQ typing by PCR amplification using sequence-specific primers (PCR-SSP): assessment after 1 year of routine use by three laboratories. Eur J Immunogenet 1994; 21: 105-123.
29. Mantel N, Mocarelli P, Marocchi A, Brambilla P, Baretta R. Stratified analysis of multivariate clinical data: application of a Mantel-Haenszel approach. Stat Med 1983; 2: 259-266.
30. Paul SR, Donner A. A comparison of tests of homogeneity of odds ratios in K 2 × 2 tables. Stat Med 1989; 8: 1455-1468.
31. Gart JJ. Alternative analyses of contingency tables. JR Stat Assoc Ser B 1966; 28: 164-169.